These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

168 related items for PubMed ID: 12858327

  • 1. Tianeptine: a novel strategy of psychopharmacological treatment of children with autistic disorder.
    Niederhofer H, Staffen W, Mair A.
    Hum Psychopharmacol; 2003 Jul; 18(5):389-93. PubMed ID: 12858327
    [Abstract] [Full Text] [Related]

  • 2. Clonidine treatment of hyperactive and impulsive children with autistic disorder.
    Jaselskis CA, Cook EH, Fletcher KE, Leventhal BL.
    J Clin Psychopharmacol; 1992 Oct; 12(5):322-7. PubMed ID: 1479049
    [Abstract] [Full Text] [Related]

  • 3. St John's Wort treating patients with autistic disorder.
    Niederhofer H.
    Phytother Res; 2009 Nov; 23(11):1521-3. PubMed ID: 19274686
    [Abstract] [Full Text] [Related]

  • 4. Double-blind, placebo-controlled study of amantadine hydrochloride in the treatment of children with autistic disorder.
    King BH, Wright DM, Handen BL, Sikich L, Zimmerman AW, McMahon W, Cantwell E, Davanzo PA, Dourish CT, Dykens EM, Hooper SR, Jaselskis CA, Leventhal BL, Levitt J, Lord C, Lubetsky MJ, Myers SM, Ozonoff S, Shah BG, Snape M, Shernoff EW, Williamson K, Cook EH.
    J Am Acad Child Adolesc Psychiatry; 2001 Jun; 40(6):658-65. PubMed ID: 11392343
    [Abstract] [Full Text] [Related]

  • 5. Cyproheptadine in the treatment of autistic disorder: a double-blind placebo-controlled trial.
    Akhondzadeh S, Erfani S, Mohammadi MR, Tehrani-Doost M, Amini H, Gudarzi SS, Yasamy MT.
    J Clin Pharm Ther; 2004 Apr; 29(2):145-50. PubMed ID: 15068403
    [Abstract] [Full Text] [Related]

  • 6. [Review of psychopharmacological treatments in adolescents and adults with autistic disorders].
    Baghdadli A, Gonnier V, Aussilloux C.
    Encephale; 2002 Apr; 28(3 Pt 1):248-54. PubMed ID: 12091786
    [Abstract] [Full Text] [Related]

  • 7. A double-blind, placebo-controlled study of the efficacy of transdermal clonidine in autism.
    Fankhauser MP, Karumanchi VC, German ML, Yates A, Karumanchi SD.
    J Clin Psychiatry; 1992 Mar; 53(3):77-82. PubMed ID: 1548248
    [Abstract] [Full Text] [Related]

  • 8. Randomized, controlled, crossover trial of methylphenidate in pervasive developmental disorders with hyperactivity.
    Research Units on Pediatric Psychopharmacology Autism Network.
    Arch Gen Psychiatry; 2005 Nov; 62(11):1266-74. PubMed ID: 16275814
    [Abstract] [Full Text] [Related]

  • 9. Levetiracetam versus placebo in childhood and adolescent autism: a double-blind placebo-controlled study.
    Wasserman S, Iyengar R, Chaplin WF, Watner D, Waldoks SE, Anagnostou E, Soorya L, Hollander E.
    Int Clin Psychopharmacol; 2006 Nov; 21(6):363-7. PubMed ID: 17012983
    [Abstract] [Full Text] [Related]

  • 10. Neuropharmacologic treatment of bronchial asthma with the antidepressant tianeptine: a double-blind, crossover placebo-controlled study.
    Lechin F, van der Dijs B, Orozco B, Jara H, Rada I, Lechin ME, Lechin AE.
    Clin Pharmacol Ther; 1998 Aug; 64(2):223-32. PubMed ID: 9728903
    [Abstract] [Full Text] [Related]

  • 11. Risperidone in the treatment of disruptive behavioral symptoms in children with autistic and other pervasive developmental disorders.
    Shea S, Turgay A, Carroll A, Schulz M, Orlik H, Smith I, Dunbar F.
    Pediatrics; 2004 Nov; 114(5):e634-41. PubMed ID: 15492353
    [Abstract] [Full Text] [Related]

  • 12. Guanfacine in children with autism and/or intellectual disabilities.
    Handen BL, Sahl R, Hardan AY.
    J Dev Behav Pediatr; 2008 Aug; 29(4):303-8. PubMed ID: 18552703
    [Abstract] [Full Text] [Related]

  • 13. Naltrexone in young autistic children: a double-blind, placebo-controlled crossover study.
    Kolmen BK, Feldman HM, Handen BL, Janosky JE.
    J Am Acad Child Adolesc Psychiatry; 1995 Feb; 34(2):223-31. PubMed ID: 7896655
    [Abstract] [Full Text] [Related]

  • 14. Randomized controlled trial of transdermal secretin on behavior of children with autism.
    Ratliff-Schaub K, Carey T, Reeves GD, Rogers MA.
    Autism; 2005 Jul; 9(3):256-65. PubMed ID: 15937041
    [Abstract] [Full Text] [Related]

  • 15. Risperidone: new indication. Behavioural disorders in children with autism or mental disabilities: no progress.
    Prescrire Int; 2006 Apr; 15(82):43-5. PubMed ID: 16602211
    [Abstract] [Full Text] [Related]

  • 16. Tricyclic antidepressants for autism spectrum disorders (ASD) in children and adolescents.
    Hurwitz R, Blackmore R, Hazell P, Williams K, Woolfenden S.
    Cochrane Database Syst Rev; 2012 Mar 14; (3):CD008372. PubMed ID: 22419332
    [Abstract] [Full Text] [Related]

  • 17. Naltrexone in autistic children: a double-blind and placebo-controlled study.
    Campbell M, Anderson LT, Small AM, Locascio JJ, Lynch NS, Choroco MC.
    Psychopharmacol Bull; 1990 Mar 14; 26(1):130-5. PubMed ID: 2196621
    [Abstract] [Full Text] [Related]

  • 18. Naltrexone in young autistic children: replication study and learning measures.
    Kolmen BK, Feldman HM, Handen BL, Janosky JE.
    J Am Acad Child Adolesc Psychiatry; 1997 Nov 14; 36(11):1570-8. PubMed ID: 9394942
    [Abstract] [Full Text] [Related]

  • 19. Multisite, double-blind, placebo-controlled trial of porcine secretin in autism.
    Owley T, McMahon W, Cook EH, Laulhere T, South M, Mays LZ, Shernoff ES, Lainhart J, Modahl CB, Corsello C, Ozonoff S, Risi S, Lord C, Leventhal BL, Filipek PA.
    J Am Acad Child Adolesc Psychiatry; 2001 Nov 14; 40(11):1293-9. PubMed ID: 11699803
    [Abstract] [Full Text] [Related]

  • 20. Tianeptine as a slightly effective therapeutic option for attention-deficit hyperactivity disorder.
    Niederhofer H.
    Neuropsychobiology; 2004 Nov 14; 49(3):130-3. PubMed ID: 15034228
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.